Vabysmo (faricimab-svoa)

Vabysmo is the newest FDA cleared treatment for Neovascular or Wet AMD, and Diabetic Retinopathy.

Wet AMD is a type of Advanced Age Related Macular Degeneration in which patients loose vision quickly due to leakage or bleeding from abnormal blood vessels growing beneath the retina. Patients treated with Vabysmo have a 95% chance of maintaining their vision over two years and a 40% chance of doubling their vision with treatment. Patients treated with Vabysmo generally require injections less frequently then those treated with other drugs.

Diabetic Retinopathy is a  condition where patients with diabetes loose vision due to swelling of the center of the retina (Macular Edema) or from abnormal blood vessels in the retina that bleed or cause retinal detachments. 

If you or someone you know would like more information on Vabsymo, please contact us for an appointment.